# Impact of Apolipoprotein E4 on blood-brain barrier integrity in target replacement murine models: a systematic review and meta-analysis.

- **DOI:** [10.1186/s13195-026-02018-3](https://doi.org/10.1186/s13195-026-02018-3)
- **Rating:** Limited (2.8 out of 5)
- **Verdict:** A focused synthesis maps APOE4-related vascular dysfunction in humanised mice, but inconsistent study accounting prevents the pooled conclusions from being fully trusted.
- **Framework version:** v5.9
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-10-08
- **Evaluation page:** https://www.nabu.science/paper/10.1186%2Fs13195-026-02018-3

## Key claims

1. APOE4 mice showed a consistent reduction in CBF associated with APOE4 genotype (SMD = -2.87, 95% CI: -5.14 to -0.604, df = 2.66)
   - Support: Tentative
   - Type: Primary finding
   - Basis: three heterogeneous studies with limited RVE degrees of freedom do not establish consistency across models
   - Location: Abstract; Results—Cerebral Blood Flow; Figure 2
2. A random-effects meta-analysis (k = 6) showed a negative but non-significant trend toward reduced vascular morphology markers in APOE4 versus APOE3 mice
   - Support: Tentative
   - Type: Secondary
   - Basis: a small heterogeneous marker synthesis has unresolved five-versus-six study accounting
   - Location: Results—Vascular Morphology; Figure 3
3. Narrative synthesis identified three key mechanistic pathways linking APOE4 to vascular dysfunction
   - Support: Tentative
   - Type: Secondary
   - Basis: heterogeneous narrative studies identify associations but do not establish integrated causal pathways
   - Location: Abstract; Results—Narrative Summary; Figure 4
4. Preclinical evidence demonstrates that APOE4 drives alterations in vascular functioning primarily through involvement with pathways related to vascular metabolism, ECM remodelling and BBB leakage
   - Support: Tentative
   - Type: Secondary
   - Basis: causal framing exceeds the small heterogeneous and largely narrative preclinical evidence base
   - Location: Abstract—Conclusions; Conclusion

## Strengths

- **Focused synthesis of vascular APOE4 evidence** The review integrates CBF, vascular morphology, BBB leakage, and mechanistic findings within humanised APOE mouse models, giving the field a focused evidence map.
  - Dimension: contribution
  - Location: Abstract; Results—Study Outcomes and APOE4 Contributions to BBB Destabilisation
- **Registered and structured review methods** The protocol and search were registered, four databases were searched, and screening and outcome extraction used independent reviewers. SYRCLE and CAMARADES were used to characterise bias and reporting quality.
  - Dimension: methodological rigour
  - Location: Methods—Identification and Search Strategy, Study Selection and Data Extraction, and Risk of Bias
- **Actionable preclinical research agenda** The Discussion identifies longitudinal, cell-specific, and standardised studies as next steps and organises future investigation around three mechanistic axes.
  - Dimension: application pathway
  - Location: Discussion and Future Perspectives; Figure 4

## Limitations

- **Included-study accounting is internally inconsistent** Results reports 18 included studies, Table 3 lists 21, and Discussion reports 22 studies assessed for quality. This uncertainty affects confidence in both the evidence map and the risk-of-bias summary.
  - Dimension: methodological rigour
  - Location: Results—Literature Retrieval and Quality Assessment; Table 3; Discussion, paragraph 2
- **Morphology synthesis composition remains unclear** Results describes a six-study morphology meta-analysis, while Figure 3 says five studies, and the marker-to-study descriptions do not consistently align with Table 2. The pooled estimate therefore cannot be tracked confidently from the article.
  - Dimension: reporting
  - Location: Table 2; Results—Vascular Morphology; Figure 3 caption
- **Conclusions exceed pooled evidence certainty** The conclusion describes consistent pathogenic vascular-morphology alterations even though the pooled morphology estimate is non-significant, while the CBF estimate rests on three studies with limited RVE degrees of freedom.
  - Dimension: positioning
  - Location: Results—Cerebral Blood Flow and Vascular Morphology; Figures 2–3; Conclusion

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Noted
  - A random-effects meta-analysis (k = 6) showed a negative but non-significant trend toward reduced vascular morphology markers in APOE4 versus APOE3 mice: "A random-effects meta-analysis (k = 6) showed a negative but non-significant trend toward reduced vascular morphology markers in APOE4 versus APOE3 mice" (Results — Vascular Morphology) vs "Standardised mean differences (SMDs) comparing APOE4 mice vs. APOE3 mice were calculated across five studies assessing vascular morphology using IHC markers (laminin, collagen-IV, CD31)." (Figure 3 caption). The Results identify six studies whereas the figure caption identifies five, and the supplied text does not establish which study set generated the pooled estimate. → Effect on result unclear
  - Narrative synthesis identified three key mechanistic pathways linking APOE4 to vascular dysfunction: "Lin et al., 2020 [39]EFAD (5xFAD × APOE-TR; E4FAD and E3FAD lines), mixed C57BL/6 × SJL background (substrain not specified); breeders originally obtained from Dr. M. J. LaDu.n = 8/group2 monthsMale, Female[39]" (Table 1 — Lin 2020) vs "In 7-month-old E4FAD mice, mTOR hyperactivity was associated with reduced P-glycoprotein (P-gp) transport at the BBB" (Results — Insulin/mTOR Signalling). Table 1 assigns Lin 2020 an age of two months whereas the mechanistic account assigns seven months, with no information establishing whether these refer to different experimental stages or which age applies to the reported outcome. → Effect on result unclear
  - Narrative synthesis identified three key mechanistic pathways linking APOE4 to vascular dysfunction: "Thomas et al., 2017 [33]APOE3 vs. APOE4 (E3FAD vs. E4FAD)BBBBBB LeakageFibrinogen IHC (% area occupied)22 monthsCortex" (Table 2 — Thomas 2017) vs "Thomas et al. [33] identified that 8-month-old female E4FAD mice exhibited ~ 65% higher cortical fibrinogen levels and increased sodium fluorescein (NaFl) leakage compared to other groups" (Results — Occludin & ECM). The fibrinogen comparison attributed to Thomas 2017 is assigned an age of 22 months in Table 2 but eight months in the narrative, so its correct age cannot be established from the supplied text. → Effect on result unclear
  - Narrative synthesis identified three key mechanistic pathways linking APOE4 to vascular dysfunction: "Yamazaki et al., 2020 [37]APOE3 vs. APOE4BBBBasement Membrane IntegrityCollagen-IV immunofluorescence (relative intensity)22 monthsCortex" (Table 2 — Yamazaki 2020) vs "Immunofluorescence confirmed diminished collagen-IV in 8-month-old APOE4 mice." (Results — Occludin & ECM). The collagen-IV immunofluorescence result attributed to Yamazaki 2020 is assigned an age of 22 months in Table 2 but eight months in the narrative, leaving the age of the evidence used in the temporal interpretation unresolved. → Effect on result unclear
  - Minor reporting notes (1):
    - Descriptive: "Study quality and reporting were evaluated using the CAMARADES checklist and SYRCLE Risk of Bias tool across all 18 studies. The mean CAMARADES score was 7.2/10 (72%), ranging from 4 to 9.5 (Table 3)." (Results — Quality Assessment and Risk of Bias) vs "Using the CAMARADES checklist and SYRCLE Risk of Bias (RoB) tool [47], we assessed 22 studies that met eligibility criteria for reporting quality." (Discussion, paragraph 2). Counting Table 3 gives 21 study rows rather than 18 or 22, and their printed scores sum to 152, giving a mean of 152/21 = 7.2381 that rounds to the reported 7.2. → Conclusion holds
- **Reporting and transparency:** Noted. Marker-to-study labels, model descriptions and eligibility reporting require clarification; the supplied text does not establish corrected pooled effects or changes to the mechanistic conclusions.
  - Conflict of interest: not stated · Preregistration: declared · Data availability: not stated · Code availability: not stated
- **Reference integrity:** Clean
  - 69 references in manuscript
  - 66 of 66 checkable references found in an index
  - 3 are books, websites or datasets — counted, but not index-checkable
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
